Naftidrofuryl Noumed Life Sciences (Naftidrofuryl Oxalate)

Naftidrofuryl acts on the peripheral vascular system to alleviate symptoms of reduced blood flow.

• Intermittent claudication: improves walking distance by enhancing microcirculation in the lower limbs.
• Peripheral arterial disease: reduces vascular resistance, alleviating limb ischemia.
• Cerebrovascular insufficiency: supports cerebral blood flow, helping to mitigate transient ischemic symptoms.

• Naftidrofuryl selectively antagonizes serotonin (5‑HT2) receptors on peripheral blood vessels, leading to vasodilation of arterioles and improved microcirculatory flow. By decreasing vascular resistance, it enhances oxygen delivery to ischemic tissues without significant effect on heart rate or cardiac output.

Adverse reactions may occur with Naftidrofuryl therapy.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Headache: transient cranial discomfort.
• Dizziness: sensation of light‑headedness, especially on standing.
• Abdominal pain: mild cramping or discomfort.
• Flushing: temporary reddening of the skin.
• Gastro‑intestinal upset: occasional diarrhoea or constipation.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure requiring medical attention.
• Allergic reaction: rash, itching, swelling, or anaphylaxis.
• Hepatic enzyme elevation: abnormal liver function tests.
• Blood dyscrasias: rare cases of leukopenia or thrombocytopenia.
• Cardiac arrhythmia: uncommon irregular heartbeat.
• Syncope: fainting episodes linked to vasodilation.

Before initiating Naftidrofuryl, consider the following precautions.

• Cardiovascular assessment: evaluate baseline blood pressure and cardiac status.
• Hypotension monitoring: watch for signs of low blood pressure, especially when standing.
• Hepatic function: use cautiously in patients with liver impairment.
• Serotonin antagonist hypersensitivity: avoid in individuals with known allergy to the drug.
• Concomitant antihypertensives: adjust doses to prevent excessive blood pressure fall.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Naftidrofuryl may interact with other medicines; review patient medication lists.

Major Interactions (Avoid)

• Potent vasodilators (e.g., nitroglycerin): risk of severe hypotension.
• MAO inhibitors: potential for exaggerated serotonergic effects.
• Strong CYP2D6 inhibitors (e.g., quinidine): may increase Naftidrofuryl plasma levels.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents (beta‑blockers, ACE inhibitors): may require dose adjustment.
• Other serotonergic drugs (triptans): monitor for additive serotonin antagonism.
• Diuretics: watch for enhanced blood pressure reduction.